Related Experiment Video
Updated: Aug 23, 2026

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Analysis of a novel prophage-encoded group A Streptococcus extracellular phospholipase A(2)
Michal J Nagiec1, Benfang Lei, Sarah K Parker
1Center for Human Bacterial Pathogenesis Research, Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Abstract:
Group A Streptococcus (GAS) is an important human pathogen that causes many types of infections, including pharyngitis and severe invasive diseases. We recently sequenced the genome of a serotype M3 strain and identified a prophage-encoded secreted phospholipase A(2) designated SlaA. To study SlaA structure-activity relationships, 20 site-specific mutants were constructed by alanine-replacement mutagenesis and purified to apparent homogeneity. Enzymatic activity was greatly reduced by alanine replacement of amino acid residues previously described as crucial in the catalytic mechanism of secreted phospholipase A(2). Similarly, substitution of five residues in an inferred Ca(2+)-binding loop and three residues in the inferred active site region resulted in loss of activity of 76.5% or greater relative to the wild-type enzyme. Analysis of enzyme substrate specificity confirmed SlaA as a phospholipase A(2), with activity against multiple phospholipid head groups and acyl chains located at the sn-2 position. PCR analysis of 1,189 GAS strains representing 48 M protein serotypes commonly causing human infections identified the slaA gene in 129 strains of nine serotypes (M1, M2, M3, M4, M6, M22, M28, M75, and st3757). Expression of SlaA by strains of these serotypes was confirmed by Western immunoblot. SlaA production increased rapidly and substantially on co-culture with Detroit 562 human pharyngeal epithelial cells. Together, these data provide new information about a novel extracellular enzyme that participates in GAS-human interactions.
Insights
Group A Streptococcus secretes a novel enzyme, SlaA (secreted phospholipase A2), crucial for pathogen-host interactions. This enzyme
Area of Science:
- Microbiology
- Enzymology
- Molecular Biology
Background:
- Group A Streptococcus (GAS) is a significant human pathogen causing pharyngitis and invasive diseases.
- A novel secreted phospholipase A2, SlaA, was identified in the GAS M3 strain genome.
- Understanding SlaA's role is key to deciphering GAS pathogenesis.
Purpose of the Study:
- To investigate the structure-activity relationships of the secreted phospholipase A2 (SlaA) enzyme.
- To determine the substrate specificity and prevalence of SlaA in GAS strains.
- To analyze SlaA expression in response to human epithelial cells.
Main Methods:
- Site-specific mutagenesis (alanine-replacement) to create 20 SlaA mutants.
- Enzymatic assays to assess activity and substrate specificity.
- PCR and Western immunoblotting to detect the slaA gene and SlaA protein in GAS strains.
- Co-culture experiments with human pharyngeal epithelial cells.
Main Results:
- Mutagenesis confirmed key residues for SlaA catalytic activity and Ca2+-binding.
- SlaA demonstrated phospholipase A2 activity against various phospholipids.
- The slaA gene was found in 129 of 1,189 GAS strains across nine serotypes.
- SlaA production was upregulated upon co-culture with pharyngeal cells.
Conclusions:
- SlaA is a novel extracellular enzyme involved in GAS-human interactions.
- The enzyme's activity is dependent on specific catalytic and Ca2+-binding residues.
- SlaA is present in several GAS serotypes and its expression is modulated by host cell contact.
Related Concept Videos
Streptococcal Pharyngitis
Determinants of Bacterial Pathogenicity and Virulence
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Formation of Lipopolysaccharides
Viral Replication: Lytic Cycle
